Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients

Non-nucleoside reverse-transcriptase inhibitor plus integrase strand transfer inhibitor–based dual therapies are an attractive simplification, nucleoside reverse transcriptase inhibitor-sparing strategy for experienced human immunodeficiency virus-infected patients. Thus, we performed a 24-week real...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccardi, Niccolò, Del Puente, Filippo, Taramasso, Lucia, Di Biagio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748463/
https://www.ncbi.nlm.nih.gov/pubmed/30798670
http://dx.doi.org/10.1177/2325958218821657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748463/
https://www.ncbi.nlm.nih.gov/pubmed/30798670
http://dx.doi.org/10.1177/2325958218821657

Ejemplares similares